Annotation Detail
Information
- Associated Genes
- MTTP
- Associated Variants
-
MTTP MUTATION
MTTP MUTATION - Associated Disease
- Philadelphia chromosome-positive acute lymphoblastic leukemia
- Source Database
- DisGeNET
- Description
- Despite the clinical efficacy achieved with frontline therapies for BCR-ABL-positive disease, such as imatinib and second-generation ABL inhibitors like nilotinib or dasatinib that were originally designed to override insensitivity to imatinib, drug resistance still remains a challenge, especially for patients with advanced-stage chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Pubmed
- 25331939
- Section of the abstract supporting the evidence
- ALL_TEXT_1/3
- Number of the section of the abstract supporting the evidence
- 1
- Number of the sentence supporting the evidence
- 1
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.00407162808120455
Drugs